The U.S. Food and Drug Administration on Wednesday approved Johnson & Johnson's drug to treat a type of muscle-weakening ...

Health and Human Services employees were told in March to remove 'nicknames' from email systems and signatures to comply with ...

IMAAVY TM (nipocalimab-aahu) is a first-in-class FcRn (neonatal Fc receptor) inhibitor, designed to reduce the levels of ...

Nipocalimab-aahu is a human immunoglobulin G1 monoclonal antibody that binds with high affinity to the neonatal Fc receptor, resulting in the reduction of circulating IgG levels.

I have said — and my other family members have been super clear about this — that we disagree again and again and again on the things that he’s said.' ...

The chocolate-covered nuts came in two sizes - .6oz and 4 oz bags - and were sent to stores in 16 states and Guam.

The maternal mortality rate rose to 19 deaths per 100,000 live births, up from 18.6 the year before. The CDC counts women who ...

Neotonics brings together a thoughtful mix of probiotics and plant-based ingredients, each chosen for their unique role in ...

Q1 2025 Earnings Conference Call April 30, 2025 11:30 AM ETCompany ParticipantsWade Walke - SVP, IRBrett Monia ...

Ionis Pharmaceuticals showcases strong Q1 2025 results with TRYNGOLZA's successful launch and raised revenue guidance.